Drug Profile
LB 201 - LogicBio Therapeutics
Alternative Names: LB-201 - LogicBio TherapeuticsLatest Information Update: 21 Nov 2022
Price :
$50
*
At a glance
- Originator LogicBio Therapeutics
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Inborn error metabolic disorders